Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Star of the week: the Ministry of Health and Social Services

Home Focus Star of the week: the Ministry of Health and Social Services

Star of the week goes to the Ministry of Health and Social Services (MoHSS)  that started with the roll-out of a  more effective HIV drug that has fewer side effects as of Tuesday. The drug also has high genetic barriers to developing resistance. The drug is called Tenofovir/ Lamivudine/ Dolutegravir (TLD).

The U.S. government, through funding from the United States President’s Emergency Plan for AIDS Relief (PEPFAR) and support from the U.S. Centre for Disease Control and Prevention (CDC) and the United States Agency for International Development (USAID) is supporting the MoHSS with the transition to TLD.
Health Ministry Executive Director Ben Nangombe and U.S. Ambassador Lisa Johnson launched the roll-out of the medication at Nathaniel Maxwilili Clinic in Babylon informal settlement on Tuesday. This comes after the ministry announced last month that as from October, they will introduce this most advanced HIV drug.

Namibia has over 200 000 people living with HIV. The country has gone beyond achieving HIV fast-track targets of the UNAIDS by ensuring that more than 90 % of people living with HIV know their status, are on treatment and viral load is suppressed.
“Today is a historic day because we are starting the transition to a new regimen in the treatment of HIV/AIDS,” said Nangombe.